Exact Sciences Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 10.49, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average collection period, for Exact Sciences's accounts receivable remained unchanged at 35 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 236 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 953 to 1728.

What is Receivable Turnover Ratio?
What is Exact Sciences Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EXAS Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	19.96 %	15.57 %	33.91 %	16.3 %	22.27 %
Y / Y Revenue Change	23.12 %	18.01 %	13.98 %	9.76 %	10.29 %
Receivable Turnover Ratio (TTM)	10.49	10.37	10.29	10.79	10.95
EXAS's Total Ranking	# 1728	# 953	# 1643	# 1027	# 398
Accounts Receivable average collection period days	35	35	35	34	33
Seq. Receivable Change	-2.42 %	-13.38 %	26.28 %	12.38 %	-5.99 %
Seq. Revenue Change	3.35 %	4.87 %	14.71 %	-0.96 %	-0.95 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 18
Healthcare Sector	# 237
Overall Market	# 1728

Receivable Turnover Ratio Statistics
High	Average	Low
0.59	0.38	0.02
(Sep 30 2017)		(March 31, 2014)

EXAS Company Profile • Back to EXAS Efficiency Comparisons • Compare EXAS Receivables Turnover Ratio to its Competitors

Financial Statements
Exact Sciences's Accounts Receivable	$ 299 Millions	Visit EXAS's Balance sheet
Exact Sciences's Sales TTM	$ 3,245 Millions	Visit EXAS's Income Statement
Sources of EXAS's Revenues		Visit EXAS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EXAS's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EXAS's Growth Rates	EXAS's Roa	EXAS's Inventory Turnover Ratio	EXAS's Dividend Comparisons
EXAS's Profitability Ratios	EXAS's Roi	EXAS's Asset Turnover Ratio	EXAS's Dividend Growth
EXAS's Valuation Ratios	EXAS's Roe	EXAS's Financial Strength Ratios	EXAS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Innovative Eyewear Inc	28.53	$ 2.662 Millions	$ 0.093 Millions
Aesthetic Medical International Holdings Group Limited	28.50	$ 106.636 Millions	$ 3.742 Millions
Puretech Health Plc	28.24	$ 4.659 Millions	$ 0.165 Millions
Newgenivf Group Limited	27.02	$ 4.726 Millions	$ 0.175 Millions
Evotec Se	26.89	$ 882.978 Millions	$ 32.835 Millions
Electrocore Inc	26.63	$ 31.800 Millions	$ 1.194 Millions
Innovage Holding Corp	26.44	$ 915.371 Millions	$ 34.626 Millions
Premier Air Charter Holdings Inc	26.15	$ 31.878 Millions	$ 1.219 Millions
Telix Pharmaceuticals Ltd	26.01	$ 803.438 Millions	$ 30.889 Millions
Biontech Se	25.93	$ 3,214.288 Millions	$ 123.984 Millions
Polomar Health Services, Inc.	25.80	$ 0.648 Millions	$ 0.025 Millions
Cv Sciences Inc	25.56	$ 11.388 Millions	$ 0.446 Millions
Keros Therapeutics Inc	24.31	$ 257.786 Millions	$ 10.604 Millions
Legend Biotech Corporation	24.21	$ 1,028.900 Millions	$ 42.499 Millions
Valneva Se	23.01	$ 195.618 Millions	$ 8.501 Millions
Longeveron Inc	22.20	$ 1.199 Millions	$ 0.054 Millions
Lifemd Inc	21.48	$ 193.686 Millions	$ 9.018 Millions
Fonar Corporation	21.42	$ 106.031 Millions	$ 4.950 Millions
Neuraxis Inc	21.11	$ 3.569 Millions	$ 0.169 Millions
Biorestorative Therapies Inc	20.88	$ 0.360 Millions	$ 0.017 Millions
Arvinas Inc	19.93	$ 262.600 Millions	$ 13.175 Millions
Voyager Therapeutics Inc	19.59	$ 40.374 Millions	$ 2.061 Millions
Sonida Senior Living Inc	19.55	$ 381.141 Millions	$ 19.494 Millions
Siga Technologies Inc	19.47	$ 94.575 Millions	$ 4.856 Millions
Kiniksa Pharmaceuticals International Plc	19.45	$ 677.564 Millions	$ 34.828 Millions
Lipocine Inc	18.38	$ 1.977 Millions	$ 0.108 Millions
Wave Life Sciences Ltd	18.34	$ 59.102 Millions	$ 3.223 Millions
Vystar Corporation	18.31	$ 0.055 Millions	$ 0.003 Millions
Nurix Therapeutics Inc	17.68	$ 83.980 Millions	$ 4.750 Millions
Icecure Medical Ltd	17.17	$ 3.379 Millions	$ 0.197 Millions

Date modified: 2026-06-22T16:30:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.